Cantel Medical Corp. To Present At The Sidoti & Company 19th Annual Emerging Growth Institutional Investor Forum

LITTLE FALLS, N.J., March 2, 2015 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMN) announced today that Andrew A. Krakauer, CEO, will be presenting at the Sidoti & Company 19th Annual Emerging Growth Institutional Investor Forum. The formal presentation is scheduled for 2:00 PM ET on Monday, March 16, 2015 at the Grand Hyatt Hotel, New York. In addition, Mr. Krakauer, and Seth Yellin, Senior VP-Corporate Development, will be available for separate one-on-one meetings during the day.

About Cantel Medical Corp.      
Cantel Medical is a leading global company dedicated to delivering innovative infection prevention and control products and service for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives.  Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products, and specialty packaging for infectious and biological specimens. Additionally, we provide technical service for our products.  For further information, visit the Cantel website at www.cantelmedical.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cantel-medical-corp-to-present-at-the-sidoti--company-19th-annual-emerging-growth-institutional-investor-forum-300043181.html

SOURCE Cantel Medical Corp.

[ Back To TMCnet.com's Homepage ]